SCHEMBL4757405

SCHEMBL4757405

Cc1sc(NC(=O)c2cccc(Cl)c2O)nc1NS(C)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
KLKB1 P03952 1/20 0.42
KDR P35968 1/20 0.42
MAPT P10636 2/20 0.41
GRM4 Q14833 2/20 0.41
PLAU P00749 2/20 0.40
PLAT P00750 2/20 0.40
F2 P00734 1/20 0.40
F10 P00742 1/20 0.40
P2RX1 P51575 1/20 0.40
P2RX4 Q99571 1/20 0.40
P2RX7 Q99572 1/20 0.40
TMPRSS4 Q9NRS4 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757428 0.81 NPC1 (0.42) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL4757410 0.79 NPC1 (0.42) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL4757423 0.76 RAB9A (0.39) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL10114188 0.75 RAB9A (0.51) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL4756736 0.72 P2RX1 (0.43) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL4757378 0.69 NPC1 (0.55) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL4756660 0.68 RAB9A (0.48) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL13524032 0.68 CCNE1 (0.50) MEN1KMT2ANPC1RAB9AKLKB1
SCHEMBL4756594 0.68 MEN1 (0.45) MEN1KMT2AKLKB1KDRMAPT
SCHEMBL17422731 0.67 RAB9A (0.57) MEN1KMT2ANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885NPC1 585/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.